Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosome Aberrations | 129 | 2022 | 1767 | 5.640 |
Why?
|
Translocation, Genetic | 114 | 2018 | 1388 | 4.930 |
Why?
|
Karyotyping | 175 | 2017 | 1172 | 3.810 |
Why?
|
In Situ Hybridization, Fluorescence | 127 | 2023 | 2500 | 3.310 |
Why?
|
Chromosomes, Human, Pair 12 | 46 | 2018 | 430 | 2.570 |
Why?
|
Lipoma | 37 | 2013 | 292 | 2.400 |
Why?
|
Soft Tissue Neoplasms | 47 | 2022 | 1151 | 2.200 |
Why?
|
Cytogenetics | 21 | 2022 | 198 | 1.950 |
Why?
|
Chromosomes, Human, Pair 1 | 26 | 2015 | 635 | 1.820 |
Why?
|
Oncogene Proteins, Fusion | 34 | 2023 | 1591 | 1.770 |
Why?
|
Chromosomes, Human, Pair 6 | 19 | 2024 | 375 | 1.600 |
Why?
|
Chromosome Banding | 63 | 2016 | 260 | 1.590 |
Why?
|
Chromosome Deletion | 30 | 2024 | 1387 | 1.570 |
Why?
|
Chromosomes, Human, Pair 17 | 23 | 2014 | 419 | 1.570 |
Why?
|
Cytogenetic Analysis | 23 | 2022 | 271 | 1.540 |
Why?
|
Chromosomes, Human, Pair 11 | 21 | 2013 | 410 | 1.500 |
Why?
|
Trisomy | 21 | 2016 | 260 | 1.480 |
Why?
|
Uterine Neoplasms | 38 | 2020 | 1434 | 1.450 |
Why?
|
Kidney Neoplasms | 37 | 2020 | 4312 | 1.440 |
Why?
|
Gene Rearrangement | 34 | 2023 | 1122 | 1.430 |
Why?
|
High Mobility Group Proteins | 16 | 2002 | 176 | 1.230 |
Why?
|
HMGA2 Protein | 19 | 2017 | 102 | 1.210 |
Why?
|
Chromosomes, Human, Pair 7 | 18 | 2007 | 311 | 1.180 |
Why?
|
Carcinoma, Renal Cell | 23 | 2020 | 3217 | 1.110 |
Why?
|
Leiomyoma | 27 | 2016 | 654 | 1.070 |
Why?
|
Fibrosarcoma | 12 | 2022 | 308 | 1.070 |
Why?
|
Leukemia, Myeloid, Acute | 24 | 2022 | 3606 | 1.010 |
Why?
|
Chromosome Disorders | 22 | 2011 | 499 | 1.000 |
Why?
|
Chromosomes, Human, Pair 8 | 16 | 2017 | 452 | 0.990 |
Why?
|
Myelodysplastic Syndromes | 12 | 2022 | 1401 | 0.940 |
Why?
|
Polyps | 12 | 2021 | 197 | 0.920 |
Why?
|
Chromosomes, Human, Pair 20 | 8 | 2011 | 127 | 0.910 |
Why?
|
Chromosomes, Human | 11 | 2017 | 442 | 0.890 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 11 | 2024 | 1628 | 0.850 |
Why?
|
Liposarcoma | 18 | 2015 | 283 | 0.810 |
Why?
|
Metaphase | 9 | 2012 | 144 | 0.800 |
Why?
|
Chromosomes, Human, Pair 22 | 17 | 2008 | 346 | 0.760 |
Why?
|
Myeloproliferative Disorders | 5 | 2022 | 612 | 0.740 |
Why?
|
Transcription Factors | 29 | 2023 | 12100 | 0.700 |
Why?
|
Chromosomes, Human, Pair 9 | 13 | 2011 | 534 | 0.700 |
Why?
|
Neoplasms, Muscle Tissue | 5 | 2020 | 67 | 0.680 |
Why?
|
Fibroma | 10 | 2010 | 190 | 0.670 |
Why?
|
Adenosarcoma | 5 | 2021 | 36 | 0.660 |
Why?
|
Chromosomes, Human, Pair 15 | 11 | 2013 | 363 | 0.640 |
Why?
|
Janus Kinase 2 | 4 | 2011 | 541 | 0.640 |
Why?
|
Gene Amplification | 12 | 2015 | 1085 | 0.640 |
Why?
|
Chromosomes, Human, Pair 16 | 13 | 2010 | 342 | 0.630 |
Why?
|
DNA-Binding Proteins | 25 | 2023 | 9590 | 0.610 |
Why?
|
Neoplasm Proteins | 24 | 2018 | 3613 | 0.600 |
Why?
|
Leiomyosarcoma | 15 | 2016 | 424 | 0.600 |
Why?
|
Sarcoma | 20 | 2018 | 1786 | 0.580 |
Why?
|
Chromosomes, Human, Pair 14 | 12 | 2011 | 286 | 0.580 |
Why?
|
Chromosomes, Human, Pair 19 | 6 | 2009 | 347 | 0.580 |
Why?
|
Isochromosomes | 3 | 2018 | 16 | 0.580 |
Why?
|
Endometrial Neoplasms | 10 | 2017 | 1361 | 0.570 |
Why?
|
Immunohistochemistry | 46 | 2022 | 11064 | 0.560 |
Why?
|
Sarcoma, Endometrial Stromal | 7 | 2017 | 93 | 0.560 |
Why?
|
Chromosomes, Human, Pair 2 | 8 | 2004 | 313 | 0.540 |
Why?
|
Chromosomes, Human, Pair 3 | 10 | 2012 | 313 | 0.530 |
Why?
|
Chromosomes, Human, Y | 2 | 2021 | 161 | 0.510 |
Why?
|
Leiomyomatosis | 5 | 2016 | 69 | 0.510 |
Why?
|
Humans | 426 | 2024 | 760261 | 0.510 |
Why?
|
Burkitt Lymphoma | 5 | 2022 | 333 | 0.500 |
Why?
|
Salivary Gland Neoplasms | 5 | 2023 | 304 | 0.500 |
Why?
|
Adenoma, Oxyphilic | 5 | 2001 | 148 | 0.490 |
Why?
|
Thrombocythemia, Essential | 2 | 2018 | 107 | 0.490 |
Why?
|
Ring Chromosomes | 8 | 2017 | 21 | 0.470 |
Why?
|
Chromosomes, Human, X | 5 | 2011 | 320 | 0.460 |
Why?
|
Proto-Oncogenes | 3 | 2005 | 320 | 0.460 |
Why?
|
Fibrous Dysplasia of Bone | 3 | 2000 | 52 | 0.450 |
Why?
|
Oncogene Proteins | 6 | 2018 | 721 | 0.440 |
Why?
|
Hematologic Neoplasms | 4 | 2022 | 1899 | 0.440 |
Why?
|
Chromosomes, Human, Pair 10 | 9 | 2012 | 276 | 0.440 |
Why?
|
X Chromosome | 13 | 2001 | 815 | 0.430 |
Why?
|
Genetic Markers | 28 | 2016 | 2608 | 0.430 |
Why?
|
Female | 267 | 2024 | 391011 | 0.430 |
Why?
|
Chromosomes, Human, Pair 21 | 5 | 2005 | 228 | 0.420 |
Why?
|
Eosinophilia | 4 | 2022 | 560 | 0.420 |
Why?
|
Receptors, Steroid | 2 | 2023 | 154 | 0.420 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2023 | 62 | 0.420 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2022 | 1539 | 0.410 |
Why?
|
Neoplasms, Second Primary | 5 | 2022 | 1060 | 0.400 |
Why?
|
Bone Neoplasms | 13 | 2014 | 2532 | 0.400 |
Why?
|
Lymphoma, B-Cell | 9 | 2017 | 935 | 0.400 |
Why?
|
Monosomy | 6 | 2000 | 52 | 0.390 |
Why?
|
Bone Marrow | 12 | 2023 | 2918 | 0.390 |
Why?
|
Adult | 183 | 2023 | 219847 | 0.390 |
Why?
|
RNA-Binding Protein EWS | 9 | 2018 | 210 | 0.390 |
Why?
|
Middle Aged | 178 | 2024 | 220175 | 0.390 |
Why?
|
Ovarian Neoplasms | 9 | 2020 | 4875 | 0.390 |
Why?
|
Mesothelioma | 5 | 2018 | 806 | 0.380 |
Why?
|
Receptor Protein-Tyrosine Kinases | 8 | 2022 | 1614 | 0.380 |
Why?
|
Teratoma | 3 | 2018 | 403 | 0.370 |
Why?
|
Chromosome Inversion | 6 | 2012 | 118 | 0.370 |
Why?
|
Chromosomes, Human, Pair 5 | 7 | 2017 | 385 | 0.370 |
Why?
|
Giant Cell Tumors | 6 | 2002 | 90 | 0.370 |
Why?
|
Chromosome Mapping | 19 | 2009 | 4625 | 0.370 |
Why?
|
Sarcoma, Synovial | 11 | 2012 | 151 | 0.370 |
Why?
|
Pleural Neoplasms | 4 | 2019 | 609 | 0.360 |
Why?
|
Dermatofibrosarcoma | 4 | 2001 | 48 | 0.360 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2020 | 35 | 0.360 |
Why?
|
Primary Myelofibrosis | 2 | 2009 | 210 | 0.360 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 9 | 2016 | 1401 | 0.350 |
Why?
|
Calmodulin-Binding Proteins | 5 | 2013 | 232 | 0.350 |
Why?
|
Male | 213 | 2024 | 359413 | 0.350 |
Why?
|
Bone Cysts, Aneurysmal | 4 | 2005 | 70 | 0.330 |
Why?
|
Aged | 129 | 2024 | 168995 | 0.330 |
Why?
|
Thrombocytosis | 1 | 2009 | 82 | 0.320 |
Why?
|
Liposarcoma, Myxoid | 6 | 2012 | 60 | 0.320 |
Why?
|
Genes, myc | 2 | 2012 | 395 | 0.320 |
Why?
|
Cytodiagnosis | 1 | 2013 | 432 | 0.320 |
Why?
|
Carcinoma | 6 | 2023 | 2334 | 0.320 |
Why?
|
Hamartoma | 6 | 2000 | 235 | 0.320 |
Why?
|
Neoplasms | 18 | 2020 | 22066 | 0.310 |
Why?
|
Diagnosis, Differential | 28 | 2016 | 12968 | 0.310 |
Why?
|
Prenatal Diagnosis | 2 | 2016 | 1262 | 0.310 |
Why?
|
Testicular Neoplasms | 5 | 2023 | 800 | 0.310 |
Why?
|
Gene Fusion | 5 | 2022 | 354 | 0.310 |
Why?
|
Dupuytren Contracture | 2 | 1999 | 66 | 0.300 |
Why?
|
Smooth Muscle Tumor | 3 | 2016 | 63 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2016 | 995 | 0.300 |
Why?
|
Oncogenes | 5 | 2023 | 1221 | 0.290 |
Why?
|
Nuclear Proteins | 9 | 2019 | 5793 | 0.290 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2016 | 2415 | 0.290 |
Why?
|
Pineal Gland | 2 | 1998 | 157 | 0.290 |
Why?
|
Uterine Diseases | 2 | 2021 | 117 | 0.280 |
Why?
|
High-Throughput Nucleotide Sequencing | 10 | 2021 | 3618 | 0.280 |
Why?
|
Angiomyolipoma | 2 | 1998 | 184 | 0.270 |
Why?
|
Gene Deletion | 9 | 2019 | 2668 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 6 | 2015 | 368 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2014 | 8498 | 0.270 |
Why?
|
Adenoma | 9 | 2001 | 2148 | 0.270 |
Why?
|
Tendons | 3 | 2002 | 552 | 0.270 |
Why?
|
Hypertriglyceridemia | 1 | 2010 | 316 | 0.270 |
Why?
|
Fibromatosis, Aggressive | 4 | 2000 | 125 | 0.260 |
Why?
|
Aged, 80 and over | 61 | 2021 | 58947 | 0.260 |
Why?
|
Chromosomes, Human, Pair 18 | 7 | 2007 | 246 | 0.260 |
Why?
|
Mediastinal Neoplasms | 4 | 2017 | 402 | 0.260 |
Why?
|
Receptors, Thyroid Hormone | 3 | 2023 | 199 | 0.250 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 3 | 2018 | 490 | 0.250 |
Why?
|
Germinoma | 4 | 2004 | 132 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 749 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 9 | 2019 | 17766 | 0.240 |
Why?
|
Myofibroma | 3 | 2015 | 45 | 0.240 |
Why?
|
DNA, Neoplasm | 19 | 2012 | 1745 | 0.240 |
Why?
|
Muscle Neoplasms | 3 | 2001 | 133 | 0.240 |
Why?
|
HMGA1a Protein | 9 | 2000 | 61 | 0.240 |
Why?
|
Leukemia | 5 | 2022 | 1522 | 0.230 |
Why?
|
Mucin-4 | 3 | 2014 | 33 | 0.230 |
Why?
|
Leukemia, Myeloid | 2 | 2005 | 696 | 0.230 |
Why?
|
Fusion Proteins, bcr-abl | 3 | 2018 | 431 | 0.230 |
Why?
|
Gene Expression Profiling | 18 | 2021 | 9388 | 0.230 |
Why?
|
Tumor Cells, Cultured | 20 | 2007 | 6131 | 0.230 |
Why?
|
Chondrosarcoma | 8 | 2008 | 296 | 0.220 |
Why?
|
Mutation | 18 | 2024 | 29950 | 0.220 |
Why?
|
Hypotension | 1 | 2010 | 883 | 0.220 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 17 | 2015 | 4573 | 0.220 |
Why?
|
Lung Neoplasms | 15 | 2021 | 13249 | 0.220 |
Why?
|
Myxosarcoma | 2 | 2022 | 11 | 0.220 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2018 | 685 | 0.220 |
Why?
|
Oncogene Fusion | 3 | 2017 | 81 | 0.220 |
Why?
|
Thymoma | 2 | 1996 | 187 | 0.220 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2021 | 237 | 0.210 |
Why?
|
RNA-Binding Proteins | 6 | 2013 | 1892 | 0.210 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 184 | 0.210 |
Why?
|
Adolescent | 71 | 2022 | 87747 | 0.210 |
Why?
|
Nephroma, Mesoblastic | 2 | 2001 | 24 | 0.210 |
Why?
|
Phyllodes Tumor | 3 | 1998 | 53 | 0.200 |
Why?
|
Granuloma, Plasma Cell | 4 | 2010 | 80 | 0.200 |
Why?
|
Fever | 1 | 2010 | 1618 | 0.200 |
Why?
|
Thymus Neoplasms | 2 | 1996 | 274 | 0.200 |
Why?
|
Myoepithelioma | 2 | 2013 | 26 | 0.200 |
Why?
|
Ribosomal Proteins | 1 | 2024 | 359 | 0.200 |
Why?
|
Trans-Activators | 5 | 2007 | 2861 | 0.190 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 3 | 2018 | 493 | 0.190 |
Why?
|
Cell Nucleus | 6 | 2023 | 2909 | 0.190 |
Why?
|
Endometrial Stromal Tumors | 2 | 2015 | 46 | 0.190 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2023 | 113 | 0.190 |
Why?
|
Vulvar Neoplasms | 3 | 2010 | 265 | 0.190 |
Why?
|
Y Chromosome | 6 | 1999 | 205 | 0.190 |
Why?
|
Kidney Tubules, Collecting | 1 | 2001 | 163 | 0.190 |
Why?
|
Neoplasms, Multiple Primary | 5 | 2021 | 586 | 0.180 |
Why?
|
14-3-3 Proteins | 2 | 2012 | 221 | 0.180 |
Why?
|
Nerve Sheath Neoplasms | 5 | 2001 | 167 | 0.180 |
Why?
|
Carcinoma, Embryonal | 2 | 2009 | 37 | 0.180 |
Why?
|
Granulosa Cell Tumor | 2 | 1999 | 72 | 0.180 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 1999 | 377 | 0.180 |
Why?
|
Aneuploidy | 4 | 1998 | 551 | 0.180 |
Why?
|
Adenocarcinoma, Clear Cell | 2 | 2001 | 218 | 0.180 |
Why?
|
Prognosis | 21 | 2024 | 29636 | 0.180 |
Why?
|
Neoplasms, Fibrous Tissue | 2 | 1999 | 20 | 0.180 |
Why?
|
Chromosomes, Human, Pair 13 | 4 | 1999 | 194 | 0.180 |
Why?
|
Leukemia, Erythroblastic, Acute | 3 | 2016 | 176 | 0.180 |
Why?
|
Haploidy | 2 | 2011 | 133 | 0.180 |
Why?
|
Clone Cells | 7 | 2016 | 1663 | 0.180 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2021 | 93 | 0.170 |
Why?
|
Abdominal Neoplasms | 2 | 2012 | 286 | 0.170 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2014 | 679 | 0.170 |
Why?
|
Chordoma | 2 | 2002 | 346 | 0.170 |
Why?
|
Nuclear Envelope | 1 | 2021 | 165 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2020 | 79 | 0.170 |
Why?
|
Tenosynovitis | 2 | 1999 | 57 | 0.170 |
Why?
|
Genetic Diseases, Inborn | 1 | 2004 | 601 | 0.170 |
Why?
|
Fibroma, Desmoplastic | 1 | 1999 | 6 | 0.170 |
Why?
|
Histiocytoma, Malignant Fibrous | 2 | 2011 | 55 | 0.170 |
Why?
|
Adenoma, Pleomorphic | 2 | 2017 | 75 | 0.170 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2019 | 25 | 0.170 |
Why?
|
Philadelphia Chromosome | 1 | 2020 | 117 | 0.170 |
Why?
|
Glioma, Subependymal | 1 | 1999 | 3 | 0.170 |
Why?
|
Prostatic Hyperplasia | 2 | 2021 | 531 | 0.170 |
Why?
|
Immunophenotyping | 13 | 2022 | 1870 | 0.160 |
Why?
|
Vascular Neoplasms | 2 | 2016 | 167 | 0.160 |
Why?
|
Diagnostic Errors | 4 | 2021 | 1266 | 0.160 |
Why?
|
RNA Helicases | 1 | 2020 | 146 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 9 | 2015 | 4494 | 0.160 |
Why?
|
Recurrence | 7 | 2022 | 8487 | 0.160 |
Why?
|
Antigens, Neoplasm | 3 | 2020 | 1999 | 0.160 |
Why?
|
Ureteral Neoplasms | 1 | 1999 | 110 | 0.160 |
Why?
|
RNA-Binding Protein FUS | 3 | 2012 | 75 | 0.160 |
Why?
|
Kidney Pelvis | 1 | 1999 | 188 | 0.160 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2022 | 2927 | 0.160 |
Why?
|
Myometrium | 4 | 2011 | 176 | 0.160 |
Why?
|
Osteoblastoma | 1 | 1998 | 24 | 0.160 |
Why?
|
Rhabdomyosarcoma | 3 | 2010 | 361 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 1999 | 173 | 0.150 |
Why?
|
Brain Neoplasms | 7 | 2010 | 8984 | 0.150 |
Why?
|
Mesonephroma | 2 | 2015 | 21 | 0.150 |
Why?
|
Molecular Biology | 2 | 2023 | 581 | 0.150 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 117 | 0.150 |
Why?
|
Peritoneal Neoplasms | 2 | 2018 | 706 | 0.150 |
Why?
|
Genetic Testing | 1 | 2011 | 3530 | 0.150 |
Why?
|
Fibroadenoma | 1 | 1998 | 41 | 0.150 |
Why?
|
Genomic Instability | 3 | 2020 | 704 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 4 | 5 | 2013 | 556 | 0.150 |
Why?
|
Young Adult | 27 | 2023 | 58673 | 0.150 |
Why?
|
Telomere | 4 | 2003 | 934 | 0.150 |
Why?
|
Synovial Membrane | 3 | 2002 | 524 | 0.150 |
Why?
|
Osteoma, Osteoid | 1 | 1998 | 90 | 0.150 |
Why?
|
In Situ Hybridization | 8 | 2016 | 1900 | 0.150 |
Why?
|
Mosaicism | 1 | 2021 | 466 | 0.150 |
Why?
|
Calreticulin | 1 | 2018 | 115 | 0.150 |
Why?
|
Epithelioid Cells | 2 | 2014 | 60 | 0.140 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 223 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 256 | 0.140 |
Why?
|
Collagen | 4 | 2000 | 2635 | 0.140 |
Why?
|
Chloride Channels | 1 | 2018 | 221 | 0.140 |
Why?
|
Intestinal Neoplasms | 2 | 1991 | 311 | 0.140 |
Why?
|
Chondroma | 1 | 1997 | 53 | 0.140 |
Why?
|
Biopsy, Fine-Needle | 2 | 2013 | 1111 | 0.140 |
Why?
|
Myxoma | 3 | 2006 | 114 | 0.140 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2017 | 55 | 0.140 |
Why?
|
Sclerosis | 3 | 2014 | 210 | 0.140 |
Why?
|
Ovarian Diseases | 1 | 1998 | 136 | 0.140 |
Why?
|
Child | 49 | 2022 | 79758 | 0.140 |
Why?
|
E1A-Associated p300 Protein | 1 | 2017 | 123 | 0.140 |
Why?
|
Pelvic Neoplasms | 1 | 2018 | 248 | 0.140 |
Why?
|
Spinal Cord Neoplasms | 1 | 1999 | 264 | 0.140 |
Why?
|
Biopsy | 12 | 2018 | 6775 | 0.130 |
Why?
|
Mitogens | 1 | 2016 | 230 | 0.130 |
Why?
|
Leukemia, Hairy Cell | 1 | 2016 | 83 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 286 | 0.130 |
Why?
|
Carcinogens | 1 | 1998 | 449 | 0.130 |
Why?
|
Fibrocystic Breast Disease | 1 | 1996 | 103 | 0.130 |
Why?
|
Remission Induction | 3 | 2019 | 2394 | 0.130 |
Why?
|
Peripheral Nervous System Neoplasms | 4 | 2001 | 125 | 0.130 |
Why?
|
Pyrazoles | 3 | 2020 | 1992 | 0.130 |
Why?
|
Co-Repressor Proteins | 5 | 2023 | 191 | 0.130 |
Why?
|
Amino Acid Substitution | 2 | 2011 | 1737 | 0.130 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2016 | 96 | 0.130 |
Why?
|
Pancytopenia | 1 | 2016 | 101 | 0.130 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1996 | 102 | 0.120 |
Why?
|
Esophageal Neoplasms | 2 | 2017 | 1651 | 0.120 |
Why?
|
Histiocytoma, Benign Fibrous | 4 | 2000 | 63 | 0.120 |
Why?
|
Adipocytes | 3 | 2012 | 1179 | 0.120 |
Why?
|
Nuclear Receptor Coactivator 2 | 2 | 2011 | 40 | 0.120 |
Why?
|
Fibromatosis, Abdominal | 1 | 1994 | 21 | 0.120 |
Why?
|
DNA Copy Number Variations | 2 | 2014 | 2008 | 0.120 |
Why?
|
Ribonucleoproteins | 1 | 1997 | 372 | 0.120 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 332 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2016 | 2563 | 0.120 |
Why?
|
DNA Helicases | 1 | 2020 | 854 | 0.120 |
Why?
|
Adamantinoma | 1 | 2014 | 9 | 0.120 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2016 | 778 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2011 | 3774 | 0.120 |
Why?
|
Breast Diseases | 1 | 1997 | 443 | 0.120 |
Why?
|
Mesenchymoma | 3 | 2004 | 49 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1008 | 0.120 |
Why?
|
DNA Mutational Analysis | 4 | 2018 | 4109 | 0.110 |
Why?
|
Pyrroles | 2 | 2010 | 1137 | 0.110 |
Why?
|
Femoral Neoplasms | 1 | 2014 | 81 | 0.110 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2013 | 33 | 0.110 |
Why?
|
Hemosiderosis | 2 | 2011 | 66 | 0.110 |
Why?
|
Tamoxifen | 1 | 1998 | 963 | 0.110 |
Why?
|
Odontogenic Tumors | 1 | 1993 | 45 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2011 | 317 | 0.110 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2010 | 91 | 0.110 |
Why?
|
Endometrium | 2 | 1998 | 403 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2022 | 9274 | 0.110 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2014 | 77 | 0.110 |
Why?
|
WT1 Proteins | 1 | 2013 | 184 | 0.110 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 124 | 0.110 |
Why?
|
Mandibular Neoplasms | 1 | 1993 | 130 | 0.110 |
Why?
|
Carcinoid Tumor | 1 | 2014 | 228 | 0.100 |
Why?
|
Cyclin D1 | 2 | 2012 | 453 | 0.100 |
Why?
|
Repressor Proteins | 4 | 2017 | 2978 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1999 | 800 | 0.100 |
Why?
|
Hodgkin Disease | 2 | 2015 | 1381 | 0.100 |
Why?
|
Child, Preschool | 31 | 2018 | 42034 | 0.100 |
Why?
|
Thecoma | 1 | 1992 | 11 | 0.100 |
Why?
|
Thyroid Neoplasms | 2 | 1999 | 2332 | 0.100 |
Why?
|
Disease-Free Survival | 7 | 2017 | 6830 | 0.100 |
Why?
|
Physical Chromosome Mapping | 2 | 2002 | 182 | 0.100 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2020 | 2277 | 0.100 |
Why?
|
Indoles | 2 | 2010 | 1830 | 0.100 |
Why?
|
Chondrosarcoma, Mesenchymal | 1 | 2011 | 12 | 0.100 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 167 | 0.100 |
Why?
|
Keratin-19 | 2 | 2008 | 33 | 0.100 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2005 | 302 | 0.100 |
Why?
|
Keratin-7 | 2 | 2008 | 55 | 0.100 |
Why?
|
Lymphocyte Subsets | 1 | 1992 | 310 | 0.100 |
Why?
|
Fatal Outcome | 5 | 2014 | 1833 | 0.100 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2013 | 251 | 0.100 |
Why?
|
Pyrimidines | 3 | 2020 | 3011 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2017 | 4024 | 0.100 |
Why?
|
Cell Cycle Proteins | 5 | 2018 | 3448 | 0.090 |
Why?
|
Histone Acetyltransferases | 2 | 2011 | 337 | 0.090 |
Why?
|
Chromosome Breakage | 8 | 2004 | 159 | 0.090 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2011 | 135 | 0.090 |
Why?
|
Zinc Fingers | 4 | 2017 | 568 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 4 | 2023 | 2804 | 0.090 |
Why?
|
Genetic Variation | 2 | 2000 | 6540 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 1997 | 1090 | 0.090 |
Why?
|
HMGA Proteins | 1 | 2010 | 7 | 0.090 |
Why?
|
Immunoenzyme Techniques | 7 | 2010 | 1705 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 381 | 0.090 |
Why?
|
Trophoblastic Neoplasms | 1 | 2020 | 88 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 1998 | 1523 | 0.090 |
Why?
|
Nuclear Pore Complex Proteins | 2 | 2022 | 158 | 0.090 |
Why?
|
Exons | 2 | 2011 | 2391 | 0.090 |
Why?
|
Lymphocytosis | 1 | 2011 | 119 | 0.090 |
Why?
|
Disease Progression | 8 | 2017 | 13505 | 0.090 |
Why?
|
Proteoglycans | 2 | 2011 | 802 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2018 | 0.090 |
Why?
|
Endodermal Sinus Tumor | 1 | 2020 | 53 | 0.090 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
Artificial Gene Fusion | 2 | 2001 | 56 | 0.090 |
Why?
|
Dysgerminoma | 1 | 1989 | 66 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2011 | 301 | 0.090 |
Why?
|
Stromal Cells | 3 | 2012 | 1327 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3929 | 0.090 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2010 | 122 | 0.080 |
Why?
|
Survival Rate | 6 | 2017 | 12806 | 0.080 |
Why?
|
Kidney Cortex | 1 | 1989 | 169 | 0.080 |
Why?
|
Phenylalanine | 1 | 2011 | 365 | 0.080 |
Why?
|
Paired Box Transcription Factors | 1 | 2010 | 207 | 0.080 |
Why?
|
Valine | 1 | 2011 | 409 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1601 | 0.080 |
Why?
|
Receptors, Cytokine | 1 | 2009 | 258 | 0.080 |
Why?
|
Acute Disease | 6 | 2022 | 7268 | 0.080 |
Why?
|
Mitosis | 4 | 2021 | 1193 | 0.080 |
Why?
|
Loss of Heterozygosity | 3 | 2006 | 659 | 0.080 |
Why?
|
Wilms Tumor | 2 | 2007 | 376 | 0.080 |
Why?
|
Ebolavirus | 1 | 2011 | 252 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2012 | 729 | 0.080 |
Why?
|
Breast Neoplasms | 6 | 2000 | 21065 | 0.080 |
Why?
|
Macrophage Activation Syndrome | 1 | 2010 | 123 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2009 | 285 | 0.080 |
Why?
|
Skin Neoplasms | 7 | 2013 | 5797 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 538 | 0.080 |
Why?
|
Apoptosis | 5 | 2016 | 9497 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 1408 | 0.080 |
Why?
|
Cloning, Molecular | 6 | 2002 | 4172 | 0.080 |
Why?
|
Tibia | 1 | 2014 | 1065 | 0.080 |
Why?
|
Infant | 20 | 2018 | 36030 | 0.070 |
Why?
|
Sarcoma, Alveolar Soft Part | 2 | 2001 | 43 | 0.070 |
Why?
|
Vidarabine | 1 | 2009 | 336 | 0.070 |
Why?
|
Polymerase Chain Reaction | 8 | 2010 | 6067 | 0.070 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 276 | 0.070 |
Why?
|
Adipose Tissue | 3 | 2001 | 3293 | 0.070 |
Why?
|
Virus Internalization | 1 | 2011 | 494 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2015 | 1378 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1729 | 0.070 |
Why?
|
Down Syndrome | 1 | 1996 | 891 | 0.070 |
Why?
|
Base Sequence | 13 | 2011 | 12447 | 0.070 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 88 | 0.070 |
Why?
|
Chromosome Fragility | 2 | 2002 | 16 | 0.070 |
Why?
|
Lipomatosis | 1 | 1988 | 112 | 0.070 |
Why?
|
Gene Dosage | 3 | 2007 | 1218 | 0.070 |
Why?
|
Nitrophenols | 1 | 2007 | 169 | 0.070 |
Why?
|
Angiolipoma | 2 | 1997 | 11 | 0.070 |
Why?
|
Alleles | 3 | 2019 | 6900 | 0.070 |
Why?
|
Retroperitoneal Neoplasms | 3 | 1999 | 329 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2007 | 105 | 0.070 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 46 | 0.070 |
Why?
|
Chromatin | 2 | 2017 | 2939 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2006 | 951 | 0.070 |
Why?
|
Laryngeal Neoplasms | 2 | 2001 | 514 | 0.070 |
Why?
|
Predictive Value of Tests | 8 | 2016 | 15273 | 0.070 |
Why?
|
Liver Neoplasms | 4 | 2005 | 4317 | 0.070 |
Why?
|
Interphase | 4 | 2011 | 228 | 0.070 |
Why?
|
Hysterectomy | 2 | 2010 | 901 | 0.070 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 475 | 0.070 |
Why?
|
Sarcoma, Clear Cell | 1 | 2006 | 72 | 0.070 |
Why?
|
CpG Islands | 1 | 2010 | 1221 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2023 | 2945 | 0.070 |
Why?
|
Fibroblasts | 3 | 2011 | 4091 | 0.070 |
Why?
|
Retrospective Studies | 18 | 2023 | 80301 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2016 | 5230 | 0.060 |
Why?
|
Flow Cytometry | 6 | 2018 | 5873 | 0.060 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11341 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1137 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2368 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2014 | 11708 | 0.060 |
Why?
|
Thigh | 3 | 1997 | 239 | 0.060 |
Why?
|
Molecular Sequence Data | 12 | 2012 | 17628 | 0.060 |
Why?
|
Ependymoma | 1 | 1988 | 320 | 0.060 |
Why?
|
Blotting, Southern | 6 | 2001 | 778 | 0.060 |
Why?
|
Urachus | 1 | 2004 | 18 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 1990 | 1229 | 0.060 |
Why?
|
Cell Lineage | 1 | 2013 | 2525 | 0.060 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 240 | 0.060 |
Why?
|
Osteosarcoma | 3 | 2014 | 898 | 0.060 |
Why?
|
Choriocarcinoma | 1 | 2004 | 121 | 0.060 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6310 | 0.060 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39254 | 0.060 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2009 | 728 | 0.060 |
Why?
|
Adenofibroma | 1 | 2003 | 25 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6545 | 0.060 |
Why?
|
RNA, Neoplasm | 4 | 2010 | 749 | 0.060 |
Why?
|
Antigens, CD34 | 2 | 1996 | 652 | 0.060 |
Why?
|
Acetyltransferases | 1 | 2004 | 231 | 0.050 |
Why?
|
Lung Diseases | 1 | 1993 | 1915 | 0.050 |
Why?
|
Desmin | 4 | 2007 | 99 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2010 | 1548 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 3 | 1991 | 3390 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2017 | 2823 | 0.050 |
Why?
|
Melanocytes | 1 | 2006 | 512 | 0.050 |
Why?
|
Lymphoma | 2 | 2009 | 1899 | 0.050 |
Why?
|
Chromosomes, Human, 16-18 | 3 | 1986 | 32 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2011 | 2874 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2696 | 0.050 |
Why?
|
Neoplasm Staging | 5 | 2017 | 11141 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2866 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2003 | 177 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2010 | 1613 | 0.050 |
Why?
|
Polyploidy | 2 | 2003 | 119 | 0.050 |
Why?
|
Chondromatosis | 1 | 2002 | 3 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2007 | 988 | 0.050 |
Why?
|
Sequence Analysis, DNA | 5 | 2018 | 4717 | 0.050 |
Why?
|
Keratins | 3 | 2006 | 497 | 0.050 |
Why?
|
Patient Admission | 1 | 2010 | 1384 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2925 | 0.050 |
Why?
|
Centrosome | 1 | 2003 | 207 | 0.050 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2002 | 103 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2007 | 1135 | 0.050 |
Why?
|
Vulva | 1 | 2022 | 82 | 0.050 |
Why?
|
Endometriosis | 1 | 2010 | 871 | 0.050 |
Why?
|
Cohort Studies | 6 | 2021 | 41317 | 0.050 |
Why?
|
Seminoma | 1 | 2023 | 134 | 0.050 |
Why?
|
Medical Oncology | 1 | 1993 | 2321 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2003 | 296 | 0.050 |
Why?
|
World Health Organization | 2 | 2022 | 1319 | 0.050 |
Why?
|
Carcinoma, Papillary | 1 | 2006 | 785 | 0.050 |
Why?
|
DNA Fragmentation | 1 | 2001 | 237 | 0.050 |
Why?
|
Antigens, CD | 7 | 2007 | 4002 | 0.050 |
Why?
|
Phenotype | 5 | 2019 | 16543 | 0.050 |
Why?
|
Neoplasm Metastasis | 6 | 2010 | 4891 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14656 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 2001 | 783 | 0.050 |
Why?
|
Cell Division | 4 | 2003 | 4462 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2019 | 454 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3731 | 0.040 |
Why?
|
Tropomyosin | 1 | 2000 | 104 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 772 | 0.040 |
Why?
|
Treatment Outcome | 11 | 2016 | 64947 | 0.040 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2000 | 44 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 44 | 0.040 |
Why?
|
Animal Population Groups | 1 | 1999 | 12 | 0.040 |
Why?
|
Genomics | 3 | 2022 | 5790 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3483 | 0.040 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2000 | 117 | 0.040 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1999 | 32 | 0.040 |
Why?
|
Time Factors | 7 | 2017 | 40133 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2011 | 473 | 0.040 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 1999 | 122 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 1999 | 42 | 0.040 |
Why?
|
Neoplasms, Connective Tissue | 1 | 1999 | 36 | 0.040 |
Why?
|
Cadherins | 1 | 2004 | 898 | 0.040 |
Why?
|
Genes, APC | 1 | 1999 | 145 | 0.040 |
Why?
|
Elastic Tissue | 1 | 1999 | 65 | 0.040 |
Why?
|
Genes, Immunoglobulin | 1 | 2020 | 287 | 0.040 |
Why?
|
Animals | 12 | 2023 | 167940 | 0.040 |
Why?
|
Incidental Findings | 1 | 2004 | 698 | 0.040 |
Why?
|
Bone Marrow Cells | 2 | 2021 | 2424 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 693 | 0.040 |
Why?
|
Hypopharynx | 1 | 1998 | 53 | 0.040 |
Why?
|
Vincristine | 2 | 2014 | 1038 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 2000 | 751 | 0.040 |
Why?
|
Aging, Premature | 1 | 1999 | 45 | 0.040 |
Why?
|
Tumor Burden | 2 | 2016 | 1897 | 0.040 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2001 | 352 | 0.040 |
Why?
|
Cluster Analysis | 4 | 2008 | 2698 | 0.040 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2001 | 286 | 0.040 |
Why?
|
Chondromatosis, Synovial | 1 | 1998 | 17 | 0.040 |
Why?
|
Adenoma, Chromophobe | 1 | 1998 | 16 | 0.040 |
Why?
|
Pharyngeal Neoplasms | 1 | 1998 | 113 | 0.040 |
Why?
|
Survival Analysis | 4 | 2019 | 10185 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2877 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2000 | 221 | 0.040 |
Why?
|
Adenocarcinoma, Papillary | 1 | 1998 | 85 | 0.040 |
Why?
|
Neurofibromin 2 | 1 | 2019 | 270 | 0.040 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 1999 | 101 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4938 | 0.040 |
Why?
|
Multiprotein Complexes | 2 | 2017 | 1120 | 0.040 |
Why?
|
Uterus | 1 | 2002 | 651 | 0.040 |
Why?
|
Antineoplastic Agents | 4 | 2014 | 13629 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12602 | 0.040 |
Why?
|
Mice, Nude | 4 | 2009 | 3605 | 0.040 |
Why?
|
Plants | 1 | 1999 | 318 | 0.040 |
Why?
|
Bile Duct Neoplasms | 1 | 2003 | 600 | 0.040 |
Why?
|
Transcription Factor CHOP | 1 | 1997 | 68 | 0.040 |
Why?
|
Sulfonamides | 1 | 2007 | 1973 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1997 | 69 | 0.040 |
Why?
|
Ploidies | 3 | 2000 | 275 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1755 | 0.040 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 1996 | 12 | 0.030 |
Why?
|
Fibronectins | 1 | 2020 | 721 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16905 | 0.030 |
Why?
|
Up-Regulation | 3 | 2012 | 4127 | 0.030 |
Why?
|
Myositis | 1 | 1999 | 269 | 0.030 |
Why?
|
Vagina | 1 | 2022 | 842 | 0.030 |
Why?
|
Granulocytes | 1 | 2018 | 551 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 1999 | 543 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2716 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1998 | 617 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2016 | 155 | 0.030 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 41 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2017 | 18968 | 0.030 |
Why?
|
Mitotic Index | 1 | 2016 | 161 | 0.030 |
Why?
|
Osteosarcoma, Juxtacortical | 1 | 1995 | 2 | 0.030 |
Why?
|
Gene Frequency | 2 | 2019 | 3605 | 0.030 |
Why?
|
Salivary Glands | 1 | 2017 | 229 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9989 | 0.030 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 1987 | 160 | 0.030 |
Why?
|
Klinefelter Syndrome | 1 | 1996 | 47 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2015 | 7854 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2002 | 1484 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 2018 | 912 | 0.030 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2016 | 398 | 0.030 |
Why?
|
Multiple Myeloma | 2 | 2010 | 5131 | 0.030 |
Why?
|
Piperazines | 2 | 2007 | 2520 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 9196 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 4 | 2007 | 1304 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 1999 | 360 | 0.030 |
Why?
|
Paraffin | 1 | 2014 | 37 | 0.030 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 185 | 0.030 |
Why?
|
Gene Expression | 4 | 2011 | 7592 | 0.030 |
Why?
|
New York City | 1 | 2017 | 723 | 0.030 |
Why?
|
Giant Cells | 1 | 1995 | 185 | 0.030 |
Why?
|
Joint Diseases | 1 | 1999 | 458 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 1998 | 769 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2011 | 13456 | 0.030 |
Why?
|
Eosinophils | 1 | 2000 | 946 | 0.030 |
Why?
|
Muscle, Smooth | 2 | 2006 | 924 | 0.030 |
Why?
|
Chromosomes, Artificial, Yeast | 3 | 2001 | 113 | 0.030 |
Why?
|
Doxorubicin | 2 | 2014 | 2207 | 0.030 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.030 |
Why?
|
Genome, Human | 3 | 2012 | 4416 | 0.030 |
Why?
|
Microarray Analysis | 2 | 2008 | 747 | 0.030 |
Why?
|
Homozygote | 1 | 1999 | 1786 | 0.030 |
Why?
|
Pulmonary Blastoma | 1 | 1994 | 41 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2010 | 2651 | 0.030 |
Why?
|
Cervix Uteri | 1 | 1998 | 585 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5640 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2016 | 20048 | 0.030 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 105 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 350 | 0.030 |
Why?
|
Clavicle | 1 | 1996 | 224 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 1999 | 1344 | 0.030 |
Why?
|
Bone Diseases | 1 | 1997 | 418 | 0.030 |
Why?
|
Spermatic Cord | 1 | 1993 | 24 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2014 | 302 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 241 | 0.030 |
Why?
|
Actins | 3 | 2007 | 2049 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2002 | 1180 | 0.030 |
Why?
|
Multigene Family | 1 | 1996 | 1079 | 0.030 |
Why?
|
Blast Crisis | 2 | 1991 | 101 | 0.030 |
Why?
|
Genital Neoplasms, Male | 1 | 1993 | 68 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1793 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 358 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5644 | 0.030 |
Why?
|
Genes | 2 | 2001 | 1845 | 0.030 |
Why?
|
Infant, Newborn | 6 | 2018 | 26168 | 0.030 |
Why?
|
Precancerous Conditions | 1 | 2000 | 978 | 0.030 |
Why?
|
Sertoli Cell Tumor | 1 | 1993 | 36 | 0.030 |
Why?
|
Terminology as Topic | 2 | 2010 | 1534 | 0.030 |
Why?
|
Transcription, Genetic | 4 | 2010 | 7593 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3106 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2006 | 1056 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.030 |
Why?
|
DNA, Complementary | 3 | 2001 | 1993 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 75 | 0.030 |
Why?
|
Premenopause | 1 | 1996 | 1039 | 0.030 |
Why?
|
Mutant Chimeric Proteins | 1 | 2011 | 20 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2016 | 625 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 516 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 2012 | 173 | 0.020 |
Why?
|
Niemann-Pick Diseases | 1 | 2011 | 27 | 0.020 |
Why?
|
Marburg Virus Disease | 1 | 2011 | 11 | 0.020 |
Why?
|
Inflammation | 3 | 2023 | 10757 | 0.020 |
Why?
|
Marburgvirus | 1 | 2011 | 19 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2014 | 278 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1999 | 1415 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1612 | 0.020 |
Why?
|
Esophagus | 1 | 2017 | 1023 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 872 | 0.020 |
Why?
|
Gene Order | 1 | 2011 | 169 | 0.020 |
Why?
|
Viral Fusion Proteins | 1 | 2011 | 99 | 0.020 |
Why?
|
RNA, Messenger | 4 | 2010 | 12762 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 724 | 0.020 |
Why?
|
Utrophin | 1 | 2010 | 17 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 2004 | 545 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 2016 | 530 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
Signal Transduction | 3 | 2009 | 23363 | 0.020 |
Why?
|
Dosage Forms | 1 | 2010 | 57 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 2010 | 142 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2202 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 976 | 0.020 |
Why?
|
Cough | 1 | 2014 | 595 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1996 | 1153 | 0.020 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2010 | 42 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 2010 | 418 | 0.020 |
Why?
|
PAX7 Transcription Factor | 1 | 2010 | 55 | 0.020 |
Why?
|
Biochemical Phenomena | 1 | 2010 | 58 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2011 | 254 | 0.020 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.020 |
Why?
|
Membrane Fusion | 1 | 2011 | 266 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10434 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1566 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2002 | 4409 | 0.020 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 1989 | 48 | 0.020 |
Why?
|
Genes, jun | 1 | 2009 | 68 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2009 | 20 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2596 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 326 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2010 | 574 | 0.020 |
Why?
|
Urethral Neoplasms | 2 | 2006 | 37 | 0.020 |
Why?
|
Extremities | 2 | 2008 | 867 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1998 | 1313 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 29725 | 0.020 |
Why?
|
Mucins | 1 | 2012 | 568 | 0.020 |
Why?
|
Femur | 1 | 1995 | 1302 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1811 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2220 | 0.020 |
Why?
|
Cell Differentiation | 3 | 2014 | 11480 | 0.020 |
Why?
|
Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2011 | 374 | 0.020 |
Why?
|
Endosomes | 1 | 2011 | 519 | 0.020 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2008 | 60 | 0.020 |
Why?
|
RNA Interference | 1 | 2017 | 2846 | 0.020 |
Why?
|
Menopause | 1 | 1996 | 1640 | 0.020 |
Why?
|
Blood | 1 | 2010 | 586 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 6 | 2014 | 20484 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2011 | 639 | 0.020 |
Why?
|
Leukemia, Lymphoid | 1 | 1988 | 309 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3443 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 896 | 0.020 |
Why?
|
Pelvic Pain | 1 | 2010 | 298 | 0.020 |
Why?
|
Mesoderm | 2 | 2001 | 671 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4264 | 0.020 |
Why?
|
Promoter Regions, Genetic | 3 | 2005 | 5784 | 0.020 |
Why?
|
Mice | 6 | 2023 | 81216 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2646 | 0.020 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2009 | 180 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1650 | 0.020 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1987 | 58 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2010 | 588 | 0.020 |
Why?
|
Ankle | 1 | 2010 | 350 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1106 | 0.020 |
Why?
|
Alternative Splicing | 2 | 2003 | 1091 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2010 | 814 | 0.020 |
Why?
|
Cell Line | 4 | 2011 | 15626 | 0.020 |
Why?
|
Activating Transcription Factor 1 | 1 | 2006 | 26 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5333 | 0.020 |
Why?
|
Biological Transport | 1 | 2011 | 2087 | 0.020 |
Why?
|
Chromosomes | 1 | 1990 | 575 | 0.020 |
Why?
|
Chromosomes, Human, 21-22 and Y | 1 | 1986 | 45 | 0.020 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 1986 | 49 | 0.020 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1986 | 77 | 0.020 |
Why?
|
Hybrid Cells | 2 | 1998 | 422 | 0.020 |
Why?
|
Cartilage | 1 | 2010 | 806 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2010 | 567 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2008 | 345 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1986 | 113 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2011 | 420 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4637 | 0.020 |
Why?
|
Leg | 1 | 1991 | 1091 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1966 | 0.020 |
Why?
|
Lysosomes | 1 | 2011 | 919 | 0.020 |
Why?
|
Hemangiopericytoma | 1 | 1986 | 71 | 0.020 |
Why?
|
Etoposide | 1 | 2007 | 630 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2006 | 3800 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2006 | 191 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2010 | 612 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2120 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10530 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 2009 | 533 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1790 | 0.020 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2004 | 46 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3665 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2007 | 877 | 0.020 |
Why?
|
Urachal Cyst | 1 | 2004 | 7 | 0.020 |
Why?
|
Cryopreservation | 1 | 1989 | 720 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12532 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9282 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4355 | 0.010 |
Why?
|
DNA Probes | 2 | 1998 | 551 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18134 | 0.010 |
Why?
|
DNA, Antisense | 1 | 2003 | 44 | 0.010 |
Why?
|
Immunoblotting | 1 | 2007 | 1649 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 833 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2006 | 649 | 0.010 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2003 | 50 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2003 | 71 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2208 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4437 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2007 | 675 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 625 | 0.010 |
Why?
|
Publishing | 1 | 2010 | 837 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1997 | 4554 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 1991 | 1347 | 0.010 |
Why?
|
Hemangiosarcoma | 1 | 2005 | 218 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8805 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2011 | 1447 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4814 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 854 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 457 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 495 | 0.010 |
Why?
|
Rad51 Recombinase | 1 | 2003 | 188 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 2004 | 370 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 5 | 2014 | 36247 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2003 | 333 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 435 | 0.010 |
Why?
|
Restriction Mapping | 2 | 1994 | 852 | 0.010 |
Why?
|
Chondroblastoma | 1 | 2002 | 48 | 0.010 |
Why?
|
Adenoviruses, Human | 1 | 2003 | 255 | 0.010 |
Why?
|
Hepatectomy | 1 | 2005 | 560 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1134 | 0.010 |
Why?
|
Osteochondroma | 1 | 2002 | 44 | 0.010 |
Why?
|
Collagen Type I | 1 | 2005 | 615 | 0.010 |
Why?
|
Survival | 1 | 2002 | 161 | 0.010 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2001 | 57 | 0.010 |
Why?
|
Intestine, Small | 1 | 1988 | 1207 | 0.010 |
Why?
|
Epiglottis | 1 | 2001 | 81 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1999 | 11902 | 0.010 |
Why?
|
Cell Cycle | 1 | 1989 | 2937 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2003 | 371 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1173 | 0.010 |
Why?
|
Testis | 1 | 2004 | 794 | 0.010 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2001 | 57 | 0.010 |
Why?
|
S100 Proteins | 1 | 2001 | 218 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.010 |
Why?
|
Point Mutation | 1 | 2006 | 1594 | 0.010 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2001 | 38 | 0.010 |
Why?
|
Dosage Compensation, Genetic | 1 | 2002 | 207 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2001 | 311 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2003 | 897 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2010 | 1262 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1994 | 2558 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2012 | 15766 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3378 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2001 | 378 | 0.010 |
Why?
|
Glucuronosyltransferase | 1 | 2000 | 130 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5039 | 0.010 |
Why?
|
Ganglioglioma | 1 | 1999 | 36 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 1999 | 19 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2001 | 258 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3491 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 2010 | 1470 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5201 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9336 | 0.010 |
Why?
|
Neurofibroma | 1 | 2000 | 94 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2811 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 1993 | 2880 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2918 | 0.010 |
Why?
|
Myosarcoma | 1 | 1998 | 1 | 0.010 |
Why?
|
Immunity | 1 | 2004 | 998 | 0.010 |
Why?
|
Laparoscopy | 1 | 2010 | 2155 | 0.010 |
Why?
|
Lumbosacral Region | 1 | 1999 | 291 | 0.010 |
Why?
|
Axilla | 1 | 2001 | 618 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8551 | 0.010 |
Why?
|
Estrogen Receptor beta | 1 | 1998 | 168 | 0.010 |
Why?
|
Pancreas | 1 | 2004 | 1677 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22041 | 0.010 |
Why?
|
Oligodendroglioma | 1 | 1999 | 279 | 0.010 |
Why?
|
Veins | 1 | 2002 | 765 | 0.010 |
Why?
|
Molecular Probes | 1 | 1999 | 313 | 0.010 |
Why?
|
Nucleic Acid Probes | 1 | 1997 | 9 | 0.010 |
Why?
|
NF-kappa B | 1 | 2006 | 2486 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1998 | 256 | 0.010 |
Why?
|
Proteins | 2 | 2003 | 6030 | 0.010 |
Why?
|
Prolactinoma | 1 | 1998 | 113 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8553 | 0.010 |
Why?
|
Appendicitis | 1 | 2004 | 674 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 21378 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2895 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2005 | 3531 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2000 | 1577 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1999 | 1121 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2000 | 656 | 0.010 |
Why?
|
Belgium | 1 | 1996 | 118 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 426 | 0.010 |
Why?
|
Telomerase | 1 | 2001 | 747 | 0.010 |
Why?
|
Cosmids | 1 | 1996 | 105 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2627 | 0.010 |
Why?
|
Prolactin | 1 | 1998 | 621 | 0.010 |
Why?
|
Organ Specificity | 1 | 2001 | 1955 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2000 | 1090 | 0.010 |
Why?
|
United States | 2 | 2016 | 72363 | 0.010 |
Why?
|
Anemia, Refractory | 1 | 1995 | 17 | 0.010 |
Why?
|
Benzamides | 1 | 2001 | 1369 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1997 | 562 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3466 | 0.010 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 1995 | 38 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1997 | 630 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13967 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2000 | 1723 | 0.010 |
Why?
|
Tyrosine | 1 | 1999 | 1440 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2819 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1999 | 1493 | 0.010 |
Why?
|
Edema | 1 | 1999 | 772 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12156 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7345 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1633 | 0.010 |
Why?
|
Neurilemmoma | 1 | 2000 | 523 | 0.010 |
Why?
|
Thyrotropin | 1 | 1998 | 832 | 0.010 |
Why?
|
beta Catenin | 1 | 1999 | 1043 | 0.010 |
Why?
|
Italy | 1 | 1996 | 840 | 0.010 |
Why?
|
RNA | 1 | 2004 | 2721 | 0.010 |
Why?
|
Fluorescence | 1 | 1996 | 750 | 0.010 |
Why?
|
Lymphocytes | 2 | 1994 | 2612 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2001 | 3618 | 0.010 |
Why?
|
DNA | 2 | 1999 | 7236 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 1998 | 638 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2001 | 3584 | 0.010 |
Why?
|
Scoliosis | 1 | 1999 | 733 | 0.010 |
Why?
|
Vimentin | 1 | 1993 | 255 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2005 | 2297 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6226 | 0.010 |
Why?
|
Myosins | 1 | 1993 | 405 | 0.010 |
Why?
|
Leukemia, T-Cell | 1 | 1991 | 101 | 0.010 |
Why?
|
Cell Survival | 1 | 2001 | 5796 | 0.010 |
Why?
|
Age Factors | 2 | 1998 | 18415 | 0.010 |
Why?
|
DNA, Satellite | 1 | 1991 | 67 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2641 | 0.010 |
Why?
|
Cytoplasm | 1 | 1995 | 1518 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1991 | 257 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 282 | 0.010 |
Why?
|
Meningioma | 1 | 1999 | 1220 | 0.010 |
Why?
|
Erythroid Precursor Cells | 1 | 1991 | 211 | 0.010 |
Why?
|
Erythroblasts | 1 | 1990 | 143 | 0.010 |
Why?
|
Centromere | 1 | 1991 | 213 | 0.010 |
Why?
|
Models, Genetic | 1 | 2000 | 3442 | 0.010 |
Why?
|
Prospective Studies | 2 | 2009 | 54263 | 0.010 |
Why?
|
Melanoma | 1 | 1988 | 5695 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2000 | 2730 | 0.010 |
Why?
|
Knee Joint | 1 | 1997 | 1662 | 0.010 |
Why?
|
Muscles | 1 | 1993 | 1581 | 0.000 |
Why?
|
Syndrome | 1 | 1995 | 3278 | 0.000 |
Why?
|
Chromosome Fragile Sites | 1 | 1988 | 26 | 0.000 |
Why?
|
Phosphorylation | 1 | 1999 | 8314 | 0.000 |
Why?
|
Risk Assessment | 1 | 2010 | 24086 | 0.000 |
Why?
|
Methylation | 1 | 1990 | 1080 | 0.000 |
Why?
|
Rabbits | 1 | 1994 | 4773 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2002 | 12412 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7512 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5498 | 0.000 |
Why?
|
Culture Media | 1 | 1986 | 899 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 1999 | 4923 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1988 | 2014 | 0.000 |
Why?
|
Kidney | 1 | 2000 | 7072 | 0.000 |
Why?
|
Glioblastoma | 1 | 1999 | 3482 | 0.000 |
Why?
|
Stem Cells | 1 | 1996 | 3525 | 0.000 |
Why?
|
Transfection | 1 | 1991 | 5782 | 0.000 |
Why?
|
Prevalence | 1 | 1998 | 15687 | 0.000 |
Why?
|
Transplantation, Heterologous | 1 | 1988 | 2378 | 0.000 |
Why?
|
Glioma | 1 | 1991 | 3420 | 0.000 |
Why?
|
Risk Factors | 1 | 2000 | 74269 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1988 | 10183 | 0.000 |
Why?
|